Hormone Research in Paediatrics · 2002 · 103 citations · 31 references
MedicineEndocrinologyMolecular BiologyEndocrine GeneticsMetabolic RegulationPharmacogeneticsCytokine Gene PolymorphismDiabetes MellitusInsulin ResistanceReceptor PolymorphismsDiabetes Mellitus AssociationsLinear RegressionMultiple RegressionPeroxisome Proliferator-activated Receptor Gamma RegulationPeroxisome Proliferator-activated Receptor GeneticsPeroxisome Proliferator-activated ReceptorsType 2 Diabetes Mellitus PathogenesisType 2 Diabetes Susceptibility
OBJECTIVE: To analyze the relationship between the peroxisome proliferator-activated receptor-gamma (PPARgamma2) Pro12Ala variant and type-2 diabetes mellitus and its correlation with some cytokine determinants of insulin resistance such as tumor necrosis factor (TNF)-alpha and leptin. METHODS: The PPARgamma2 Pro12Ala genetic polymorphism was studied in 167 type-2 diabetic patients and 63 healthy controls. Serum leptin and plasma-soluble TNF-R2 were measured. RESULTS: Women carriers of the Pro12Ala mutation exhibited higher leptin levels than women non-carriers (median 31.4 vs. 17.5 ng/ml; p < 0.005). sTNF-R2 levels did not show differences between the two genotypes. Analysis by the multiple linear regression model of leptin-body mass index controlled by the PPARgamma2 genotype showed that leptin levels were determined by the Pro12Ala mutation in type-2 diabetic women but not in men. CONCLUSIONS: PPARgamma2 seems to be implicated in leptin homeostasis in type-2 diabetic women.
31
Modulation of Insulin Activities by Leptin
Batya Cohen, Daniela Novick, Menachem Rubinstein · Science · 1996 · 722 citations
Chung‐Jen Yen, Brock A. Beamer, Carlo Negri et al. · Biochemical and Biophysical Research Communications · 1997 · 492 citations · Full text
Adele Kennedy, Thomas W. Gettys, Patricia M. Watson et al. · The Journal of Clinical Endocrinology & Metabolism · 1997 · 482 citations
Medicine, Endocrinology, Physiology +17